Alpine Global Management, LLC Anavex Life Sciences Corp. Transaction History

Alpine Global Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.31 - $12.84 $78,728 - $138,286	10,770 New	10,770 $108,000
Q3 2021 Nov 12, 2021	SELL	$16.82 - $25.75 $211,057 - $323,111	-12,548 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$16.82 - $25.75 $211,057 - $323,111	12,548 New	12,548 $225,000

152

26.5M

674K

811K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $436M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.